Tiziana Life Sciences
Price & Volume
Stats
See moreOpen | $2.13 |
Previous Close | $2.16 |
Day Range | $1.95-$2.13 |
52W Range | $0.62-$2.60 |
Market Cap | $252.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | -$3.5M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.12 |
News
See moreYahoo Finance • 7 days ago
Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody
Yahoo Finance • 23 days ago
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Yahoo Finance • 27 days ago
Tiziana Life Sciences Announces Purchase of Shares by Chairman
Yahoo Finance • 2 months ago
Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy
About
CEO | Dr. Ivor R. Elrifi Ph.D. |
CFO | Ms. Keeren Shah |
Address | 14/15 Conduit Street, London, United Kingdom, W1S 2XJ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
